SG10201807236UA - A medicinal composition of extract of seed of emblica officinalis and method of preparing the same - Google Patents

A medicinal composition of extract of seed of emblica officinalis and method of preparing the same

Info

Publication number
SG10201807236UA
SG10201807236UA SG10201807236UA SG10201807236UA SG10201807236UA SG 10201807236U A SG10201807236U A SG 10201807236UA SG 10201807236U A SG10201807236U A SG 10201807236UA SG 10201807236U A SG10201807236U A SG 10201807236UA SG 10201807236U A SG10201807236U A SG 10201807236UA
Authority
SG
Singapore
Prior art keywords
seed
extract
decreasing
emblica
emblica officinalis
Prior art date
Application number
SG10201807236UA
Other languages
English (en)
Inventor
Benny Antony
Original Assignee
Benny Antony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benny Antony filed Critical Benny Antony
Publication of SG10201807236UA publication Critical patent/SG10201807236UA/en

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01N—GAS-FLOW SILENCERS OR EXHAUST APPARATUS FOR MACHINES OR ENGINES IN GENERAL; GAS-FLOW SILENCERS OR EXHAUST APPARATUS FOR INTERNAL COMBUSTION ENGINES
    • F01N3/00—Exhaust or silencing apparatus having means for purifying, rendering innocuous, or otherwise treating exhaust
    • F01N3/08—Exhaust or silencing apparatus having means for purifying, rendering innocuous, or otherwise treating exhaust for rendering innocuous
    • F01N3/0892—Electric or magnetic treatment, e.g. dissociation of noxious components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B1/00—Electrolytic production of inorganic compounds or non-metals
    • C25B1/01—Products
    • C25B1/02—Hydrogen or oxygen
    • C25B1/04—Hydrogen or oxygen by electrolysis of water
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M8/00—Fuel cells; Manufacture thereof
    • H01M8/06—Combination of fuel cells with means for production of reactants or for treatment of residues
    • H01M8/0606—Combination of fuel cells with means for production of reactants or for treatment of residues with means for production of gaseous reactants
    • H01M8/0656—Combination of fuel cells with means for production of reactants or for treatment of residues with means for production of gaseous reactants by electrochemical means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M2250/00—Fuel cells for particular applications; Specific features of fuel cell system
    • H01M2250/20—Fuel cells in motive systems, e.g. vehicle, ship, plane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30—Hydrogen technology
    • Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30—Hydrogen technology
    • Y02E60/50—Fuel cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02T—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO TRANSPORTATION
    • Y02T90/00—Enabling technologies or technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02T90/40—Application of hydrogen technology to transportation, e.g. using fuel cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Electrochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Sustainable Development (AREA)
  • Sustainable Energy (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Combustion & Propulsion (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Toxicology (AREA)
SG10201807236UA 2013-10-08 2014-10-07 A medicinal composition of extract of seed of emblica officinalis and method of preparing the same SG10201807236UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN4565CH2013 IN2013CH04565A (fr) 2013-10-08 2013-10-08

Publications (1)

Publication Number Publication Date
SG10201807236UA true SG10201807236UA (en) 2018-09-27

Family

ID=52812591

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201807236UA SG10201807236UA (en) 2013-10-08 2014-10-07 A medicinal composition of extract of seed of emblica officinalis and method of preparing the same
SG11201504845VA SG11201504845VA (en) 2013-10-08 2014-10-07 A medicinal composition of extract of seed of emblica officinalis and method of preparing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201504845VA SG11201504845VA (en) 2013-10-08 2014-10-07 A medicinal composition of extract of seed of emblica officinalis and method of preparing the same

Country Status (10)

Country Link
US (5) US9066911B2 (fr)
EP (2) EP3542809A1 (fr)
JP (1) JP2016532724A (fr)
AU (3) AU2014333401B2 (fr)
CA (1) CA2894386C (fr)
ES (1) ES2719958T3 (fr)
IN (1) IN2013CH04565A (fr)
SG (2) SG10201807236UA (fr)
WO (1) WO2015052728A1 (fr)
ZA (1) ZA201504026B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003241146A1 (en) * 2003-03-03 2004-09-28 Benny Antony A process and technique to elevate serum high density liboprotein
CN108479105B (zh) * 2018-03-22 2019-06-21 烟台新时代健康产业有限公司 一种植物有效成分超微连续分离提取装置
CN108553935A (zh) * 2018-03-22 2018-09-21 孙学中 一种用于植物有效成分医学提取的多级粉碎装置
WO2020026104A1 (fr) * 2018-07-31 2020-02-06 Benny Antony Extrait d'emblica officinalis standardisé en diacylglycérol d'acides gras
CN110860107A (zh) * 2019-11-29 2020-03-06 林东楷 一种微胶囊包埋植物甾醇提取装置
IT202000015598A1 (it) 2020-06-29 2021-12-29 Abel Nutraceuticals S R L Estratto dalla resina della pianta protium heptaphyllum, formulazioni comprendenti tale estratto e processo di estrazione idroalcolica a pressione e temperatura controllate

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3824350A1 (de) 1988-06-09 1989-12-21 Eau De Cologne & Parfuemerie Fabrik 4711 Kosmetisches und/oder hautpflegendes mittel mit pflanzlichem wirkstoffanteil
US5405613A (en) 1991-12-11 1995-04-11 Creative Nutrition Canada Corp. Vitamin/mineral composition
JPH0628091A (ja) 1992-07-09 1994-02-04 Totoku Electric Co Ltd デジタイザセンサ板
JPH06335708A (ja) 1993-05-26 1994-12-06 Sumitomo Metal Ind Ltd ステンレス鋼板の圧延方法
FR2730408B1 (fr) 1995-02-09 1997-09-05 Hanna Claude Compositions a activite depigmentante ainsi que leurs applications
JP3621517B2 (ja) 1996-07-12 2005-02-16 稲畑香料株式会社 抗アレルギー・抗炎症剤及び抗アレルギー・抗炎症食品
DE19654635C1 (de) 1996-12-28 1998-01-08 Singh Verma Shyam B Kosmetische Zubereitungen enthaltend Extrakte von Phyllanthus emblica und Centella asiatica
US6362167B1 (en) 1999-02-17 2002-03-26 Natreon Inc. Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions
US6235721B1 (en) 1999-02-17 2001-05-22 Natreon Inc. Stabilization of vitamin C
US6290996B1 (en) 1999-02-17 2001-09-18 Natreon Inc. Method of inhibiting blood platelet aggregation
US6124268A (en) 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
DE19919585A1 (de) 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen
IL151334A0 (en) 2000-02-28 2003-04-10 Natural Remedies Private Ltd An improved herbal composition having antiallergic properties and a process for the preparation thereof
US20030008048A1 (en) 2001-06-08 2003-01-09 David Winston Methods and compositions for helping the body resist the effects of the aging process
JP2003063925A (ja) * 2001-08-23 2003-03-05 Kose Corp 皮膚外用剤
CA2480334A1 (fr) 2002-03-26 2003-10-02 Council Of Scientific And Industrial Research Effet hepatocuratif d'emblica officinalis sur l'hepatotoxicite associee au cytochrome p-450
US7001619B2 (en) 2002-03-27 2006-02-21 Council Of Scientific And Industrial Research Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
EP1560561A1 (fr) 2002-11-08 2005-08-10 Merck Patent GmbH Procede de protection de la peau contre la deterioration induite par le soleil par l'administration orale d'un extrait de i emblica officinalis /i ( i phyllantus emblica /i )
AU2003241146A1 (en) 2003-03-03 2004-09-28 Benny Antony A process and technique to elevate serum high density liboprotein
US20050089590A1 (en) 2003-10-24 2005-04-28 Chaudhuri Ratan K. Method for protection of skin against sun-induced damage by oral administration of an extract of Emblica officinalis (syn. Phyllanthus emblica)
JP5149494B2 (ja) * 2006-07-21 2013-02-20 株式会社 日本薬用食品研究所 チャまたはアッサムチャの花部含有成分とその用途
US20080286217A1 (en) * 2007-05-14 2008-11-20 Chaudhuri Ratan K Sunscreen compositions and methods
WO2009060304A2 (fr) * 2007-11-09 2009-05-14 Avesthagen Limited Extraits végétaux d'emblica officinalis et leur utilisation
JP2009179602A (ja) * 2008-01-31 2009-08-13 Chiba Univ エレウテリノシドａ、ｂ、ｃ
US20120107432A1 (en) * 2009-06-29 2012-05-03 Benny Antony Composition of extract of emblica officinalis and method of preparing the same

Also Published As

Publication number Publication date
EP3068412A4 (fr) 2016-09-21
AU2019202625A1 (en) 2019-05-09
US11125130B2 (en) 2021-09-21
ZA201504026B (en) 2016-07-27
US10953055B2 (en) 2021-03-23
US20150140142A1 (en) 2015-05-21
EP3542809A1 (fr) 2019-09-25
US20170348368A1 (en) 2017-12-07
JP2016532724A (ja) 2016-10-20
US20190201465A1 (en) 2019-07-04
CA2894386C (fr) 2019-10-22
SG11201504845VA (en) 2015-07-30
IN2013CH04565A (fr) 2015-09-25
US20150250840A1 (en) 2015-09-10
US9775869B2 (en) 2017-10-03
US20200056522A1 (en) 2020-02-20
AU2014333401A1 (en) 2015-07-02
AU2017201569A1 (en) 2017-03-23
US10485831B2 (en) 2019-11-26
EP3068412B1 (fr) 2019-02-06
AU2017201569B2 (en) 2019-01-17
ES2719958T3 (es) 2019-07-17
EP3068412A1 (fr) 2016-09-21
US20210189933A9 (en) 2021-06-24
CA2894386A1 (fr) 2015-04-16
WO2015052728A1 (fr) 2015-04-16
AU2014333401B2 (en) 2016-12-08
US9066911B2 (en) 2015-06-30

Similar Documents

Publication Publication Date Title
SG10201807236UA (en) A medicinal composition of extract of seed of emblica officinalis and method of preparing the same
WO2019066577A3 (fr) Composition pour le diagnostic et le traitement d'une maladie hépatique alcoolique, utilisant une communauté bactérienne intestinale produisant un changement d'acides gras à chaîne courte
FR2999429B1 (fr) Extrait de graines de passiflore et compositions cosmetiques, pharmaceutiques, dermatologiques ou nutraceutiques le comprenant
FR2969495B1 (fr) Extrait de parties aeriennes de maca riche en polyphenols et composition le comprenant
BR112014019927B8 (pt) Fórmula nutricional, seu método de preparação, seu uso, dispositivos e composição
AU2018201444B2 (en) High fat human milk products
WO2016030644A3 (fr) Procédé d'induction de la synthèse des phycobiliproteines
MX359463B (es) Papas no fritas.
PH12016500067A1 (en) Composition for promoting hair sprouting and hair growth
WO2012108749A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de graines de pharbitis
NZ627671A (en) Des(rhamnosyl) acteoside-containing olive extract
WO2011052935A3 (fr) Composition destinée à réduire la glycémie, contenant un extrait de smilax china l., de momordica charantia et de cordyceps militaris comme principe actif
WO2012033329A3 (fr) Composition contenant un extrait d'oenanthe javanica en tant qu'ingrédient actif pour la prévention ou le traitement de troubles de l'apprentissage ou de troubles de la mémoire, et procédé pour la préparer
TW201613555A (en) Preparation method of herbal composition with multi-functional skin protection and application thereof
WO2017220051A3 (fr) Composition pharmaceutique de chlorhydrate de bensérazide et son utilisation médicale pour abaisser la glycémie
TH144571B (th) เจลแต้มสิวจากสารสกัดประสะมังคุด
GB2528406A (en) Prebiotic composition and method of its use
RU2013114904A (ru) Нефтепротекторная композиция
WO2011025176A3 (fr) Procédé d'amélioration de l'effet de régénération de la peau de substances médicinales par double ébullition en utilisant un récipient en grès
CN106074298A (zh) 一种茉莉花香水
MX2016016661A (es) Gel formulado de una mezcla de extractos de las algas pardas fucus vesiculosus y ascophyllum nodosum y su uso como medicamento auxiliar en el control de la diabetes y método de elaboración.
CN105685687A (zh) 一种味噌蔬菜汤
Kim et al. The Comparative Study of Resonance Disorders for Vietnamese and Korean Cleft Palate Speakers using Nasometer
GR20130200216U (el) Ευεργετικο παρασκευασμα ξυδιου με βοτανα και καρπους
PH12014000096A1 (en) Herbal extract for inhibiting growth of tumor